Adipocytes: Becoming less beige with age
Stored inside the fat deposits of humans and mice are thermogenic cells known as brown and beige adipocytes which burn energy and dissipate it as heat (Sakers et al., 2022). This allows the body to stay warm when temperatures drop and to maintain energy levels in response to physical activity. As individuals age, their ability to carry out this function – known as adaptive thermogenesis – declines, but it remains unclear why.
Unlike brown adipoctyes, which are located in brown adipose tissue (such as the fat deposit between shoulder blades), beige adipocytes are generated in white adipose tissue in response to certain stimuli, such as exposure to cold. The generation and activation of beige adipocytes, known as ‘beiging’, ameliorates high blood sugar (hyperglycemia) and lipid imbalances (dyslipidemia), and prevents obesity and disruption of the metabolism, making beige adipocytes a potential therapeutic target for metabolic diseases (Bartelt and Heeren, 2014; Min et al., 2016). However, beiging upon cold exposure declines with age in both rodents and humans (Berry et al., 2017; Wang et al., 2022; Benvie et al., 2023). Now, in eLife, Patrick Seale and colleagues – including Corey Holman as first author – report the results of experiments that shed light on the cellular mechanisms responsible for this age-related shift (Holman et al., 2023).
The team (who are based at the University of Pennsylvania, Beth Israel Deaconess Medical Center, Broad Institute of MIT and Harvard, and Harvard Medical School) induced beiging in the white adipose tissue in the inguinal region (also known as the groin) of mice by treating them with a drug that stimulates this process, or exposing them to cold. As expected, comparing young (9-week-old) and aged (57-week-old) mice showed that beiging was severely blunted and delayed as mice got older.
Beige adipocytes arise from adipose stem and progenitor cells via a procees known as de novo beige adipogenesis, or by reactivating dormant beige fat cells (Wang et al., 2013; Long et al., 2014; Wang et al., 2014; Vishvanath et al., 2016; Chen et al., 2019; Shao et al., 2019). Tracing the fate of adipocyte stem and progenitor cells – identified by their expression of the gene Pdgfra – in the white adipose tissue of reporter mice showed that aged mice produced much fewer beige adipocytes from these cells than their younger counterparts (Figure 1). This observation suggests that aging blocks de novo beige adipogenesis from adipocyte stem and progenitor cells.

How adipocytes change in young and aged mice following cold exposure.
Sitting in the white adipose tissue in the inguinal region (iWAT) of mice is a population of fat cells (represented by different coloured circles) and Pdgfra+ + stem and progenitor cells (ASPCs; top left panel). When mice are exposed to cold, ASPCs mature into beige adipocytes (yellow circles with yellow spots), which burn energy and generate heat (bottom left panel). Holman et al. found that this process, known as de novo beige adipogenesis, was blocked in older mice, resulting in less beige adipocytes being generated following cold exposure (bottom right panel). Further analysis revealed three other subpopulations of adipocytes in iWAT in addition to beige adipocytes: white adipocytes expressing high levels of the thermogenic gene Npr3 (red), and white adipocytes with low (DNL-low) or high (DNL-high) levels of de novo lipogenesis (represented as yellow and green respectively). Aging altered the proportion of DNL-low and DNL-high adipoctyes, and caused adipocytes to express higher levels of Npr3 (top panels). Cold exposure decreased the proportion DNL-low adipoctyes in both young and older mice. It also increased the expression of lipogenic genes involved in de novo lipogenesis in young mice (bottom left panel), but not middle-aged mice (bottom right panel).
Image credit: Figure created using BioRender.
To investigate which factors contribute to this age-related decline, Holman et al. analyzed the genes expressed in individual stem and progenitor cells which had been isolated from white adipose tissue in the inguinal region. This revealed that the adipocyte stem and progenitor cells did not change their cellular identity in response to aging or cold exposure. Further analysis revealed that aging increased the expression of fibrogenic genes, such as Cd9, and decreased Postn and other extracellular matrix-related genes in adipocyte stem and progenitor cells, which may affect beige adipogenesis during aging. Moreover, Holman et al. found that adipocyte stem and progenitor cells from young and aged mice were equally competent at maturing into beige adipocytes when cultured in vitro. These results suggest that external factors surrounding these stem cells or in the bloodstream must be contributing to the age-related decline in de novo beige adipogenesis rather than cell autonomous differences.
Finally, to determine how aging and cold exposure impacts gene expression in mature adipocytes, Holman et al. performed single nuclei RNA sequencing analyses of inguinal white adipose tissue. This identified beige adipocytes and three other types of ‘white’ fat cell: adipocytes which expressed high levels of a thermogenic gene called Npr3 that suppresses beige adipocytes from releasing energy, and adipocytes that display either high or low levels of de novo lipogenesis – the process of generating fat tissue – (named DNL-high and DNL-low, respectively; Figure 1). Aging affected the proportion of of all four adipocyte populations in white adipose tissue, and upregulated Npr3 in the three white adipocyte populations. Interestingly, de novo lipogenesis induced by cold exposure was severely impaired in the beige and DNL-high adipocytes of aged mice. These results suggest that the dysregulation of signaling pathways, such as Npr3 signaling and lipogenesis, during aging may contribute to declining beige adipogenesis.
Senescence of adipocyte progenitor cells (Berry et al., 2017; Benvie et al., 2023) and inactivation of thermogenic genes in mature fat cells (Wang et al., 2022) have already been associated with the age-related impairment of beiging. Here, Holman et al. provide direct in vivo evidence that de novo beige adipogenesis is also blocked during aging in mice, revealing another possible mechanism to explain age-related reductions in beige adipogenesis. This work also offers a unique resource for researchers who are trying to identify the signaling pathways related to reactivating dormant beige adipocytes.
References
-
Adipose tissue browning and metabolic healthNature Reviews Endocrinology 10:24–36.https://doi.org/10.1038/nrendo.2013.204
-
A smooth muscle-like origin for beige adipocytesCell Metabolism 19:810–820.https://doi.org/10.1016/j.cmet.2014.03.025
-
Cellular origins of beige fat cells revisitedDiabetes 68:1874–1885.https://doi.org/10.2337/db19-0308
Article and author information
Author details
Publication history
Copyright
© 2023, Song and Wang
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 919
- views
-
- 87
- downloads
-
- 0
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Cell Biology
Dynamic interactions between gut mucosal cells and the external environment are essential to maintain gut homeostasis. Enterochromaffin (EC) cells transduce both chemical and mechanical signals and produce 5-hydroxytryptamine to mediate disparate physiological responses. However, the molecular and cellular basis for functional diversity of ECs remains to be adequately defined. Here, we integrated single-cell transcriptomics with spatial image analysis to identify 14 EC clusters that are topographically organized along the gut. Subtypes predicted to be sensitive to the chemical environment and mechanical forces were identified that express distinct transcription factors and hormones. A Piezo2+ population in the distal colon was endowed with a distinctive neuronal signature. Using a combination of genetic, chemogenetic, and pharmacological approaches, we demonstrated Piezo2+ ECs are required for normal colon motility. Our study constructs a molecular map for ECs and offers a framework for deconvoluting EC cells with pleiotropic functions.
-
- Cell Biology
Niemann–Pick disease type C (NPC) is a devastating lysosomal storage disease characterized by abnormal cholesterol accumulation in lysosomes. Currently, there is no treatment for NPC. Transcription factor EB (TFEB), a member of the microphthalmia transcription factors (MiTF), has emerged as a master regulator of lysosomal function and promoted the clearance of substrates stored in cells. However, it is not known whether TFEB plays a role in cholesterol clearance in NPC disease. Here, we show that transgenic overexpression of TFEB, but not TFE3 (another member of MiTF family) facilitates cholesterol clearance in various NPC1 cell models. Pharmacological activation of TFEB by sulforaphane (SFN), a previously identified natural small-molecule TFEB agonist by us, can dramatically ameliorate cholesterol accumulation in human and mouse NPC1 cell models. In NPC1 cells, SFN induces TFEB nuclear translocation via a ROS-Ca2+-calcineurin-dependent but MTOR-independent pathway and upregulates the expression of TFEB-downstream genes, promoting lysosomal exocytosis and biogenesis. While genetic inhibition of TFEB abolishes the cholesterol clearance and exocytosis effect by SFN. In the NPC1 mouse model, SFN dephosphorylates/activates TFEB in the brain and exhibits potent efficacy of rescuing the loss of Purkinje cells and body weight. Hence, pharmacological upregulating lysosome machinery via targeting TFEB represents a promising approach to treat NPC and related lysosomal storage diseases, and provides the possibility of TFEB agonists, that is, SFN as potential NPC therapeutic candidates.